These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36248903)

  • 1. Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
    Ghorbanalipoor S; Emtenani S; Parker M; Kamaguchi M; Osterloh C; Pigors M; Gross N; Khil'chenko S; Kasprick A; Patzelt S; Wortmann D; Ibrahim IO; Izumi K; Goletz S; Boch K; Kalies K; Bieber K; Smith P; Schmidt E; Ludwig RJ
    Front Immunol; 2022; 13():865241. PubMed ID: 36248903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.
    Koga H; Kasprick A; López R; Aulí M; Pont M; Godessart N; Zillikens D; Bieber K; Ludwig RJ; Balagué C
    Front Immunol; 2018; 9():1558. PubMed ID: 30050528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
    Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
    Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita.
    Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE
    Front Immunol; 2022; 13():938306. PubMed ID: 36311755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita).
    Ujiie H; Iwata H; Yamagami J; Nakama T; Aoyama Y; Ikeda S; Ishii N; Iwatsuki K; Kurosawa M; Sawamura D; Tanikawa A; Tsuruta D; Nishie W; Fujimoto W; Amagai M; Shimizu H;
    J Dermatol; 2019 Dec; 46(12):1102-1135. PubMed ID: 31646663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
    Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
    Wozniak K; Kazama T; Kowalewski C
    Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
    Mooney E; Falk RJ; Gammon WR
    Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.
    Wannick M; Assmann JC; Vielhauer JF; Offermanns S; Zillikens D; Sadik CD; Schwaninger M
    Front Immunol; 2018; 9():1890. PubMed ID: 30154797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.
    Kirtschig G; Murrell D; Wojnarowska F; Khumalo N
    Cochrane Database Syst Rev; 2003; 2003(1):CD004056. PubMed ID: 12535507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Samavedam UK; Mitschker N; Kasprick A; Bieber K; Schmidt E; Laskay T; Recke A; Goletz S; Vidarsson G; Schulze FS; Armbrust M; Schulze Dieckhoff K; Pas HH; Jonkman MF; Kalies K; Zillikens D; Gupta Y; Ibrahim SM; Ludwig RJ
    Front Immunol; 2018; 9():249. PubMed ID: 29497423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
    Akbarzadeh R; Yu X; Vogl T; Ludwig RJ; Schmidt E; Zillikens D; Petersen F
    J Dermatol Sci; 2016 Mar; 81(3):165-72. PubMed ID: 26692467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.